Bolt Biotherapeutics, Inc. Shares Outstanding (Cover Page)
Bolt Biotherapeutics, Inc. (BOLT) had Shares Outstanding (Cover Page) of 1.93 million shares as of 2026-08-04, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-04: Entity Common Stock, Shares Outstanding 1.93M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 1.92M shares.
- 2026-03-06: Entity Common Stock, Shares Outstanding 1.92M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 1.92M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-04 | 1.93M shares 10-Q · filed 2026-08-11 |
| 2026-05-05 | 1.92M shares 10-Q · filed 2026-05-12 |
| 2026-03-06 | 1.92M shares 10-K · filed 2026-03-12 |
| 2025-11-05 | 1.92M shares 10-Q · filed 2025-11-12 |
| 2025-08-07 | 1.92M shares 10-Q · filed 2025-08-14 |
| 2025-05-05 | 38.34M shares 10-Q · filed 2025-05-12 |
| 2025-03-19 | 38.34M shares 10-K · filed 2025-03-24 |
| 2024-11-06 | 38.27M shares 10-Q · filed 2024-11-12 |
| 2024-08-07 | 38.26M shares 10-Q · filed 2024-08-13 |
| 2024-05-07 | 38.13M shares 10-Q · filed 2024-05-14 |
| 2024-03-14 | 38.13M shares 10-K · filed 2024-03-21 |
| 2023-11-02 | 37.97M shares 10-Q · filed 2023-11-09 |
| 2023-07-31 | 37.95M shares 10-Q · filed 2023-08-07 |
| 2023-05-04 | 37.81M shares 10-Q · filed 2023-05-11 |
| 2023-03-23 | 37.81M shares 10-K · filed 2023-03-29 |
| 2022-11-03 | 37.66M shares 10-Q · filed 2022-11-10 |
| 2022-08-03 | 37.64M shares 10-Q · filed 2022-08-10 |
| 2022-05-05 | 37.47M shares 10-Q · filed 2022-05-12 |
| 2022-03-24 | 37.47M shares 10-K · filed 2022-03-30 |
| 2021-11-02 | 37.28M shares 10-Q · filed 2021-11-09 |
| 2021-08-06 | 37.20M shares 10-Q · filed 2021-08-12 |
| 2021-05-10 | 36.34M shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |